Sobi

Gamifant

Manufacturer:

Sobi

Gamifant HCPCS:

J9210

HCPCS Code Descriptor:

Injection, emapalumab-lzsg, 1 mg

Category:

J Code

Gamifant NDCs:

66658-0505-01, 66658-0501-01, 66658-0510-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Gamifant:

Gamifant is an Oncology drug manufactured by Sobi and administered via the Intravenous route of administration. The J Code: J9210 is aligned to the drug Gamifant.

ACCESS PRICING AND MORE BY REGISTERING

J9210 Added Date:

October 1, 2019

J9210 Effective Date:

October 1, 2019

J9210 Termination Date:

HCPCS Active

Gamifant billing and coding information can be found through Sobi at the link below:
Gamifant patient assistance information can be found through Gamifant Cares at the URL: https://www.gamifantcares.com/supportservices
Gamifant prescribing information can be found at the link below:
Information regarding Gamifant’s side effects can be found at MedlinePlus